Abstract
A vaccine is a biological preparation which enhances the immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. This agent stimulates the body immune system to recognize the agent as foreign, destroy it, and keep a record of it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines may be therapeutic (means vaccines against cancer are also being investigated; see cancer vaccine) or prophylactic (means to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), The term vaccine elucidate by Edward Jenner's 1796 use of cow pox (Latin variola vaccinia, taken from the Latin vaccīn-us, from vacca, cow), to inoculate humans, providing them protection against smallpox.1 Vaccines do not guarantee complete protection from a disease.2 This may be due to a lowered immunity in general (diabetes, steroid, HIV infection,age) or because the host's immune system does not have a B cell capable of generating antibodies to that antigen. In this case, the infection will be less severe and heal faster.3 Adjuvants are typically used to boost immune response. Most often aluminium adjuvants are used, but adjuvants like squalene are also used in some vaccines and more vaccines with squalene and phosphate adjuvants are being tested. Larger doses are used in some cases for older people (50–75 years)
References
Stefan Riedel, MD, PhD (January 2005). "Edward Jenner and the history of smallpox and vaccination". Proceedings (Bayl Univ Med Cent) 18 (1): 21–25. PMC 1200696.
Grammatikos, Alexandros P.; Mantadakis, Elpis; Falagas, Matthew E. (June 2009). "Meta-analyses on Pediatric Infections and Vaccines". Infectious Disease Clinics of North America 23 (2): 431–57. doi:10.1016/j.idc.2009.01.008. PMID 19393917.
Sullivan P (2005-04-13). "Maurice R. Hilleman dies; created vaccines". Washington Post.
Comparative efficacy of three mumps vaccines during disease outbreak in eastern Switzerland: cohort study - Schlegel et al. 319 (7206): 352 - bmj.com". Bmj.bmjjournals.com. Retrieved 2013-04-26.
Préziosi, M.; Halloran, M.E. (2003). "Effects of Pertussis Vaccination on Disease: Vaccine Efficacy in Reducing Clinical Severity". Clinical Infectious Diseases (Oxford Journals) 37 (6): 772–779. doi:10.1086/377270.
Orenstein WA, Papania MJ, Wharton ME (2004). "Measles elimination in the United States". J Infect Dis 189 (Suppl 1): S1–3. doi:10.1086/377693. PMID 15106120.
Centers for Disease Control and Prevention (CDC) (May 2008). "Measles--United States, January 1-April 25, 2008". MMWR Morb. Mortal. Wkly. Rep. 57 (18): 494– 8. PMID 18463608.
Sutter RW, Cochi SL, Melnick JL (1999). "Live attenuated polio vaccines". In Plotkin SA, Orenstein WA (eds.). Vaccines. Philadelphia: W. B. Saunders. pp. 364–408.
Questions and answers on monovalent oral polio vaccine type 1 (mOPV1) "Issued jointly by WHO and UNICEF"". CDC. "Ingredients of Vaccines — Fact Sheet". Retrieved december 20, 2009.
"Thimerosal in vaccines". Center for Biologics Evaluation and Research, U.S. Food and Drug Administration. 2007- 09-06. Retrieved 2007-10-01.
Offit PA (2007). "Thimerosal and vaccines—a cautionary tale" (PDF). N Engl J Med 357 (13): 1278–9. doi:10.1056/NEJMp078187. PMID 17898096.
IARC, World Cancer Report, (WHO), 2003.
Cancer The Role of genes, Life style and Environment by Joseph Panno.
Lollini PL, Cavallo F, Nanni P, Forni G. Vaccines for tumour prevention. Nature Reviews Cancer2006; 6(3):204–216.
Pardoll DM. Inducing autoimmune disease to treat cancer. Proc NatlAcad Sci USA 1999;96:5340–2.
Hughes AL, Verra F. Extensive polymorphism and ancient origin of Plasmodium falciparum. Trends Parasitol 2002; 18: 348–5
Offit PA (2007). Vaccinated: One Man's Quest to Defeat the World's Deadliest Diseases. Washington, DC: Smithsonian. P . 107. ISBN 0-06-122796-X
Ott JJ, Irving G, Wiersma ST (December 2012). "Long- term protective effects of hepatitis A vaccines. A systematic review". Vaccine 31 (1): 3–11. doi:10.1016/j.vaccine.2012.04.104. PMID 22609026
"Hepatitis A Vaccine Information". Vaccine Information. Immunization Info. Retrieved 2008-06-19.
Immunization Action Coalition. St. Paul, MN 55104,(651) 647-9009 www.vaccineinformation.org
Drawing Up Ready-to-Use Vaccine” www.eziz.org/assets/docs/IMM-896.pdf.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright (c) 2020 Array